DIN 02558378 — VANFLYTA 26.5 MG
VANFLYTA is a tablet of Quizartinib marketed by DAIICHI SANKYO PHARMA CANADA LIMITED. The full Quizartinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02558378
- Brand name
- VANFLYTA
- Active ingredient
- Quizartinib
- Strength
- 26.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- DAIICHI SANKYO PHARMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- FLT3 kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Quizartinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02558351 | VANFLYTA | 17.7 MG | TABLET | DAIICHI SANKYO PHARMA CANADA LIMITED | MARKETED |